CRISPR/Cas9 Genome Editing Technology

HOW CRISPR/ Cas9 Works Video

“CRISPR/Cas9 genome editing can make permanent, precisely targeted changes in patients’ chromosomes and repair the underlying genetic mutation, whereas more traditional gene therapy typically involves introducing a non-permanent copy of a gene into patients’ cells. These attributes of CRISPR/Cas9 provide a significant therapeutic edge over other gene therapy and costly earlier-generation genome editing technologies, such as zinc finger nucleases and transcription activator-like effector nucleases.” – Intellia Therapeutics

Support Our Mission

Giving to via Credit Card

$ Donation Amount:

Choose Your Donation Amount:

Select Payment Method

Offline Donation
Credit Card
PayPal

Personal Info

Title *

First Name *

Last Name

Company Name

Email Address *

Make this an anonymous donation.

Comment

Credit Card Info

This is a secure SSL encrypted payment.

Card Number *

CVC *

Cardholder Name *

Expiration *

Billing Details

Country *

Address 1 *

Address 2

City *

Region *

Zip / Postal Code *

Terms

Acceptance of any contribution, gift or grant is at the discretion of the NZ ATTR Amyloidosis Patients Association (NZAPA). The NZ ATTR Amyloidosis Patients Association (NZAPA) will not accept any gift unless it can be used or expended consistently with the purpose and mission of the NZ ATTR Amyloidosis Patients Association (NZAPA).

No irrevocable gift, whether outright or life-income in character, will be accepted if under any reasonable set of circumstances the gift would jeopardize the donor’s financial security.

The NZ ATTR Amyloidosis Patients Association (NZAPA) will refrain from providing advice about the tax or other treatment of gifts and will encourage donors to seek guidance from their own professional advisers to assist them in the process of making their donation.

The NZ ATTR Amyloidosis Patients Association (NZAPA) will accept donations of cash or publicly traded securities. Gifts of in-kind services will be accepted at the discretion of the NZ ATTR Amyloidosis Patients Association (NZAPA).

Certain other gifts, real property, personal property, in-kind gifts, non-liquid securities, and contributions whose sources are not transparent or whose use is restricted in some manner, must be reviewed prior to acceptance due to the special obligations raised or liabilities they may pose for NZ ATTR Amyloidosis Patients Association (NZAPA).

The NZ ATTR Amyloidosis Patients Association (NZAPA) will provide acknowledgments to donors meeting tax requirements for property received by the charity as a gift. However, except for gifts of cash and publicly traded securities, no value shall be ascribed to any receipt or other form of substantiation of a gift received by NZ ATTR Amyloidosis Patients Association (NZAPA).

The NZ ATTR Amyloidosis Patients Association (NZAPA) will respect the intent of the donor relating to gifts for restricted purposes and those relating to the desire to remain anonymous. With respect to anonymous gifts, the NZ ATTR Amyloidosis Patients Association (NZAPA) will restrict information about the donor to only those staff members with a need to know.

The NZ ATTR Amyloidosis Patients Association (NZAPA) will not compensate, whether through commissions, finders' fees, or other means, any third party for directing a gift or a donor to the NZ ATTR Amyloidosis Patients Association (NZAPA).

Show Terms

Agree to Terms?

Donation Total: $10.00

CRISPR/Cas9 Genome Editing Technology

Like this:

Related

Leave a Reply Cancel reply

Share this:

Like this:

Related

Related Posts

How To Be Heard At The Doctors; Patient Voice Matters

How My Pacemaker Contributed to Hypotension and Pedal Edema

Genetic Discrimination: Insurance Policies

Leave a Reply Cancel reply